Tempo Bioscience Expands Patient-Relevant iPSC-Derived Cell Models
- Tempo-iSchwann™ Human iPSC-derived Schwann Cells
- Tempo-iCardio™ Human iPSC-derived Cardiomyocytes
- Tempo-iKidneyPod™ Human iPSC-derived Kidney Proximal Tubules & Podocytes 3D Spheroids
- Tempo-iMono™ Human iPSC-derived CD14+ Monocytes
- Tempo-iPhago™ Human iPSC-derived Phagocytes
(Announcement via BusinessWire here)
Continue Reading...
Pharma Tech Outlook names Tempo Bioscience – “Top 10 Drug Discovery and Development Solution Provider of 2018”. Tempo Bioscience is featured as the cover story of the special issue. Please see the digital edition of the magazine here.
Continue Reading...